Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23354975 | 0.86 | TTR (0.32) | GAAL3MBTL1 | |
| SCHEMBL14107695 | 0.82 | EPHX1 (0.32) | EPHX1 | |
| SCHEMBL2588186 | 0.78 | EPHX1 (0.30) | EPHX1 | |
| SCHEMBL289296 | 0.72 | — | — | |
| SCHEMBL18480151 | 0.71 | EPHX1 (0.35) | EPHX1 | |
| SCHEMBL2769165 | 0.71 | — | — | |
| SCHEMBL10826139 | 0.71 | EPHX1 (0.55) | EPHX1 | |
| SCHEMBL8601058 | 0.71 | GAA (0.37) | GAAL3MBTL1 | |
| SCHEMBL244419 | 0.69 | GAA (0.39) | GAAL3MBTL1ALDH1A1 | |
| SCHEMBL10084909 | 0.69 | GAA (0.31) | GAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101687786-B | Hydroxylamine compounds and methods of use thereof | OTHERA HOLDING INC | 2013-05-22 | — | — | CN | claimed |
| WO-2019161125-A1 | BATCH PROCESSES FOR CATALYTIC CARBOXYLATION OF CELLULOSE FIBERS | INTERNATIONAL PAPER COMPANY (US) | 2019-08-22 | — | — | WO | disclosed |
| EP-2620429-A1 | Hydroxylamine compounds and methods of their use | Colby Pharmaceutical Company (US) | 2013-07-31 | — | — | EP | disclosed |
| EP-2483217-A2 | INTERNALLY CURING CEMENT BASED MATERIALS | Weyerhaeuser Nr Company (US) | 2012-08-08 | — | — | EP | disclosed |
| WO-2011041291-A2 | INTERNALLY CURING CEMENT BASED MATERIALS | WEYERHAEUSER NR COMPANY (US) | 2011-04-07 | — | — | WO | disclosed |
| EP-2125716-A2 | HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE | Othera Holding, Inc. (US) | 2009-12-02 | — | — | EP | disclosed |
| EP-2120942-A2 | DRUG RESISTANCE REVERSAL IN NEOPLASTIC DISEASE | Othera Holding, Inc. (US) | 2009-11-25 | — | — | EP | disclosed |
| US-20080280890-A1 | HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE | COLBY PHARMACEUTICAL COMPANY | 2008-11-13 | — | — | US | disclosed |
| US-20080280890-A1 | HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE | COLBY PHARMACEUTICAL COMPANY | 2008-11-13 | — | — | US | disclosed |
| WO-2008103613-A2 | HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE | OTHERA HOLDING, INC. (US) | 2008-08-28 | — | — | WO | disclosed |
| EP-1505199-A1 | Methods for making carboxylated pulp fibers | Weyerhaeuser Company (US) | 2005-02-09 | — | — | EP | disclosed |
| US-20030083491-A1 | Hypochlorite free method for preparation of stable carboxylated carbohydrate products | INTERNATIONAL PAPER CANADA PULP HOLDINGS ULC (CA) | 2003-05-01 | — | — | US | disclosed |
| US-20030051834-A1 | Method for preparation of stabilized carboxylated cellulose | WEYERHAEUSER COMPANY | 2003-03-20 | — | — | US | disclosed |
| EP-1264846-A1 | Method for preparation of stabilized carboxylated cellulose | Weyerhaeuser Company (US) | 2002-12-11 | — | — | EP | disclosed |
| EP-1264845-A2 | Hypochlorite free method for preparation of stable carboxylated carbohydrate products | Weyerhaeuser Company (US) | 2002-12-11 | — | — | EP | disclosed |
| EP-1238142-A1 | METHOD OF MAKING CARBOXYLATED CELLULOSE FIBERS AND PRODUCTS OF THE METHOD | Weyerhaeuser Company (US) | 2002-09-11 | — | — | EP | disclosed |
| US-6271382-B1 | REACTING A CYCLIC SECONDARY AMINE HAVING STERIC HINDRANCE WITH A PEROXIDE IN THE PRESENCE OF AT LEAST 1 PART BY WEIGHT OF AN ORGANIC COMPOUND HAVING A CYANO GROUP | KOEI CHEMICAL CO., LTD. (JP) | 2001-08-07 | — | — | US | disclosed |
| WO-2001029309-A1 | METHOD OF MAKING CARBOXYLATED CELLULOSE FIBERS AND PRODUCTS OF THE METHOD | WEYERHAEUSER COMPANY (US) | 2001-04-26 | — | — | WO | disclosed |
| EP-1067120-A1 | PROCESS FOR PRODUCING ORGANIC COMPOUND HAVING NITROXIDE FREE RADICAL | Koei Chemical Co., Ltd. (JP) | 2001-01-10 | — | — | EP | disclosed |
| US-4292399-A | Cobalt (III) complex imaging compositions having improved photographic properties | EASTMAN KODAK COMPANY (US) | 1981-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080280890-A1 | HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE | HDGF, HMOX1, HMOX2 | EPHX1 680/4885GAA 3200/4885L3MBTL1 4642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.